A Mechanistic Evaluation of the Interactions Between Thermoceptive and Pruriceptive Sensory Processing
En Mekanistisk undersøgelse af Interaktioner Imellem Det Thermoceptive og Det Pruriceptive Sensoriske System
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Nordjylland
-
Aalborg, Nordjylland, Denmark, 9220
- Aalborg University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy men and women
- Age 18-60 years
- Able to speak and understand English
Exclusion Criteria:
- Suffering from chronic disease
- Pregnancy or lactation
- Prior experience of adverse effects from anaesthetic, specifically Lidocaine
- Drug addiction defined as the use of cannabis, opioids or other drugs - 5 -
- Previous neurologic, musculoskeletal or mental illnesses
- Lack of ability to cooperate
- Current use of medications that may affect the trial
- Active skin diseases
- Active participation in other experiments currently ongoing or within the last 14 days
- Tattoos on volar forearms that will interfere with local skin measurements
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Histamine+cowhage+heat
|
Skin Prick Test with Histamine
Manually skin insertion of cowhage spicules
Short heat stimulation
|
|
EXPERIMENTAL: Histamine+cowhage+serotonin+pre-heating
|
Skin Prick Test with Histamine
Manually skin insertion of cowhage spicules
Mild skin pre-heating
Serotonin electrophoresis
|
|
PLACEBO_COMPARATOR: lidocaine and saline+heat
|
Short heat stimulation
Lidocaine intradermal injection
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
eVAS Itch
Time Frame: 10 minutes
|
Electronic Visual Analog Scale for itch sensation.
0-100 scale, it measures the self-estimated itch the subject experience on a scale where 0 correspond to "No itch" and 100 "Worst itch imaginable".
|
10 minutes
|
|
Skin temperature
Time Frame: 5 seconds
|
Infrared skin thermometer
|
5 seconds
|
|
eVAS Pain
Time Frame: 10 minutes
|
Electronic Visual Analog Scale for pain sensation.
0-100 scale, it measures the self-estimated pain the subject experience on a scale where 0 correspond to "No pain" and 100 "Worst pain imaginable".
|
10 minutes
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Daniele Riccio, MSc, Aalborg University
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Serotonin Agents
- Serotonin Receptor Agonists
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Histamine Agents
- Histamine Agonists
- Lidocaine
- Serotonin
- Histamine
Other Study ID Numbers
Other Study ID Numbers
- N-20180035
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.